While GenomeIndia focuses on data and discovery, the UMMID aims to ensure that the benefits of genetic science reach every ...

Patients were treated with MIPLYFFA in a 48-month open-label extension (OLE) study following the Phase 2/3, randomized, double-blind, placebo-controlled pivotal trial. The OLE data demonstrate that ...

From detecting pollutants to assessing health risks, the US EPA’s Office of Research and Development has long ensured that ...

THE Department of Health (DOH) has inaugurated the country’s first Newborn Screening Continuity Clinic (NBSCC) at the Bataan ...

JUUL GETS ITS CROWN — The FDA authorized Juul’s applications on Thursday to sell e-cigarettes in the U.S., determining ...

The critical work of those racing to cure rare pediatric diseases got an important shot in the arm today. Florida’s newly created Sunshine Genetics Consortium promises hope for children living with ...

A cohort of eight babies at risk of inheriting mitochondrial disease were born without complications after British scientists ...

This month, the streets of Harlem came alive as StartCare hosted its first Health & Resource Fair, a free event designed for families and community members, from 9:00 a.m. to 3:00 p.m., on 124th ...

The more Betsy Adler learned about her family's medical history, the more interested and concerned she became. Several of her first cousins had been treated for cancer, and three of her male ...

You fall asleep during the day. Suddenly, maybe while talking about or at school. Sometimes you meet hallucinations and loss ...

As predicted the era of universal newborn genomic screening is dawning. The UK and Florida are leading the way.